A Multiple Dose Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ABT-288 in Stable Subjects With Schizophrenia

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2008
Evaluate the safety, tolerability and pharmacokinetics of ABT-288 in order to determine the maximum tolerated dose of ABT-288 in stable schizophrenic volunteers receiving treatment with an atypical antipsychotic.
Epistemonikos ID: a89f5397856c9a257aeea9c97a5d52035b785cb3
First added on: May 05, 2024